Levetiracetam 102767-28-2 98%

Acute Research centre (ARC) is a full service provider in basic chemistry research, API development of first to file (FTF) & future generics molecules, cost effective commercial technology of existing API and Intermediates, CRAMS, synthesis and characterization of analytical standards/impurities and regulatory expertise for global markets along with cGMP support services. The API development team focuses on novel chemistry including novel polymorph and process to provide our customers with possible early entry opportunities in various markets with help of our IP expertise.